DEMUPITAMAB
UNII 3184JGF2SO

Substance Identification & Data

This profile provides standardized clinical and technical data for Demupitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3184JGF2SO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2249926-74-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3184JGF2SO
CAS Registry Number
2249926-74-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DEMUPITAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175767
National Cancer Institute reference terminology for clinical and research data.
INN ID
11211
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Demupitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DEMUPITAMAB

Common Names & Synonyms

DEMUPITAMAB [INN]
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HOMO SAPIENS MONOCLONAL ANTIBODY
IMMUNOGLOBULIN IGG1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL N63AB .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL N63AB .KAPPA.-CHAIN, DIMER
N63AB

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus